about
Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study.Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor.Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: Interference and comparison with established methodsAnti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Advances in male hormone substitution therapy.
@ast
Advances in male hormone substitution therapy.
@en
type
label
Advances in male hormone substitution therapy.
@ast
Advances in male hormone substitution therapy.
@en
prefLabel
Advances in male hormone substitution therapy.
@ast
Advances in male hormone substitution therapy.
@en
P2860
P1476
Advances in male hormone substitution therapy.
@en
P2093
Ammar Qoubaitary
Ronald S Swerdloff
P2860
P304
P356
10.1517/14656566.6.9.1493
P407
P577
2005-08-01T00:00:00Z